arXiv 2005.10779
Using the "Hidden" Genome to Improve Classification of Cancer Types
By Saptarshi Chakraborty, Colin B. Begg, et al.
Published 2020-05-21
Wiki summary
Explore the paper's summary, context, and related research on Papiers.
It is increasingly common clinically for cancer specimens to be examined using techniques that identify somatic mutations. In principle these mutational profiles can be used to diagnose the tissue of origin, a critical task for the 3-5% of tumors that have an unknown primary site. Diagnosis of primary site is also critical for screening tests that employ circulating DNA. However, most mutations observed in any new t…